Xconomy: Seattle News, Articles and Opinions

Results for “”

Entry	Author	Date	Location
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More	Alex Lash	09/20/19	National
Amazon Sets Electric Vehicle, Carbon Footprint Goals Amid Criticism	Jeff Buchanan	09/19/19	Seattle
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?	Alex Lash	09/19/19	National
Gilliland to Step Down as Head of Fred Hutch in 2020	Jeff Buchanan	09/17/19	Seattle
Innovations in Healthcare – Xconomy Seattle Life Science Forum – Nov. 6, 2019	Editors	09/17/19	Seattle
Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market	Mike Ward	09/16/19	National
Why Menlo Ventures Backed Construction Tech Firm Fieldwire	Bernadette Tansey	09/16/19	San Francisco
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More	Ben Fidler	09/13/19	National
As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle	Jeff Buchanan	09/11/19	Seattle
After First Look at House Drug Plan, Stocks Rise Slightly	Alex Lash	09/10/19	National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards	Ben Fidler	09/10/19	National
Shopify Buys 6 River Systems for $450M to Boost Fulfillment Centers	Brian Dowling	09/10/19	Boston
Your Car Is Hackable—Here Are Three Steps You Can Take	Madison Gross	09/10/19	Boston
Amazon, With More WA Workers than Microsoft, Eyes Adding 10K More	Jeff Buchanan	09/09/19	Seattle
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More	Ben Fidler	09/09/19	National
Home Buying Tech Startup Savvy Lane Lands $2M for West Coast Growth	Jeff Buchanan	09/06/19	Seattle
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone	Frank Vinluan	09/06/19	National
As Clean Power Buying Surges, LevelTen Helps Firms Track Energy Data	Jeff Buchanan	09/04/19	Seattle
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs	Frank Vinluan	09/03/19	San Francisco
Robocalls Crowd Out Real Business Calls. This Startup Has an Answer.	David Holley	08/30/19	Seattle
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More	Alex Lash	08/30/19	National
Ring Confirms Report, Says It Works With More Than 400 Police Agencies	Jeff Buchanan	08/28/19	Seattle
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight	Ben Fidler	08/28/19	New York
ThoughtSpot Nabs $248M for Accessible Analytics, Nears $2B Valuation	Bernadette Tansey	08/28/19	San Francisco
Seattle Startup Funding Tidbits: Blokable, Zenoti, PTO Exchange	Jeff Buchanan	08/27/19	Seattle
Space Venture’s Tom Neary Lands at SEngine as Chief Financial Officer	Frank Vinluan	08/27/19	Seattle
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)	Alex Lash	08/26/19	National
Why Amazon’s Ascent Spells Bad News for Mall Food Courts	Jeff Buchanan	08/23/19	Seattle
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug	Frank Vinluan	08/23/19	National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More	Frank Vinluan	08/23/19	National
Page 1 of 375	next page »